The Institute of Cancer Research, London
Multi-million-pound UK-wide platform into cancer immunotherapy launches. A new multimillion-pound research programme involving scientists from the ICR is aiming to discover why at least half of all patients fail to respond to immunotherapy or suffer from debilitating side effects.
About Us - The Institute of Cancer Research, London
The ICR is a college of the University of London, and educating and training the next generation of cancer researchers and clinicians is a core part of our mission. Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Our donors and supporters play a vital ...
Our Research - The Institute of Cancer Research, London
The Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics, cancer biology and personalised medicine – and came second of all UK universities in analysis of the 2021 Research Excellence Framework.
Cancer Therapeutics - The Institute of Cancer Research, London
A priority for the Division of Cancer Therapeutics is to tackle the challenge of tumour heterogeneity, cancer evolution and resistance to drug treatments. It has pursued the discovery and development of HSP90 inhibitors, as one way of preventing or overcoming drug resistance. The division is also interested in ways of planning drug regimens or ...
Breast cancer - The Institute of Cancer Research, London
Clinical trials. We led trials establishing the effectiveness of the chemotherapy drug carboplatin – discovered at the ICR – in triple-negative breast cancer, and of the targeted drug palbociclib in advanced, metastatic breast cancer.. Recently, results from the OlympiA trial showed that using the targeted drug olaparib to treat some women with early stage breast cancer and mutations in ...
PhDs for science graduates - Institute of Cancer Research
PhDs for science graduates. Our competitive PhD programme is designed for the next generation of world-leading scientists who want a career in cancer research. Our PhD students benefit from an above average salary and exceptional research facilities. Our aim is to attract the best minds in the world to join us in our mission - to make the ...
Centre for Immunotherapy of Cancer - The Institute of Cancer …
The Centre for Immunotherapy of Cancer (CIC), formerly known as the Centre for Translational Immunotherapy (CTI), aims to increase communication between clinicians and scientists with an interest in translational immunotherapy. We are a virtual centre, bringing together staff and students from the ICR and our partner hospital, the Royal Marsden.
Drug discovery and therapeutic innovation - The Institute of …
The ICR hosts the world-leading Centre for Cancer Drug Discovery, previously known as Cancer Research UK Cancer Therapeutics Unit, which has discovered 21 new targeted drug candidates since 2005 – more than any other academic centre in the world.Thirteen of these have gone into clinical development. In addition to this, abiraterone – …
Our strategy - The Institute of Cancer Research, London
New ICR strategy: Defeating cancer. Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Video: ICR Chief Executive Kristian Helin gives an overview of our new five-year strategy. Cancer patients are living longer and with a better quality of life.
Scientific aims and themes - The Institute of Cancer Research, …
Using in vitro assays and animal models that accurately mimic the pathological conditions and therapeutic interventions seen in the clinic, hypothesis-driven pre-clinical modelling is essential for performing mechanistic studies and testing of novel combination strategies. Theme leads: Dr Esther Arwert, Dr Erik Wennerberg, Dr Marco Bezzi.